Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

5,606 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,606 results

Early research (Phase 1)Enrolling By InvitationNCT07633197
What this trial is testing

A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)

Who this might be right for
Herpes
Changchun BCHT Biotechnology Co. 120
Early research (Phase 1)Study completedNCT02573259
What this trial is testing

A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors

Who this might be right for
Part 1MELANOMASCCHN+6 more
Pfizer 147
Not applicableUnknownNCT05550142
What this trial is testing

A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China

Who this might be right for
SARS-CoV-2
AIM Vaccine Co., Ltd. 54
Testing effectiveness (Phase 2)UnknownNCT05515042
What this trial is testing

Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults.

Who this might be right for
COVID-19
The Aurum Institute NPC 694
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07797894
What this trial is testing

Safety and Immunogenicity of HPV Vaccine in HIV-infected

Who this might be right for
HIV-infected Individuals
Beijing 302 Hospital 80
Large-scale testing (Phase 3)Study completedNCT04358731
What this trial is testing

Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine and to Compare Its Safety and Immunogenicity With That of Licensed Meningococcal ACWY Vaccine Menactra® in Healthy Individuals 18-85 Years of Age

Who this might be right for
Vaccine for Meningococcal Disease
Serum Institute of India Pvt. Ltd. 1,640
Testing effectiveness (Phase 2)Study completedNCT00415051
What this trial is testing

Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine

Who this might be right for
Rift Valley Fever
U.S. Army Medical Research and Development Command 20
Testing effectiveness (Phase 2)Ended earlyNCT01195779
What this trial is testing

Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 4
Large-scale testing (Phase 3)Study completedNCT04084769
What this trial is testing

Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)

Who this might be right for
Meningococcal Immunisation (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 570
Large-scale testing (Phase 3)Study completedNCT01175083
What this trial is testing

Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 300
Testing effectiveness (Phase 2)UnknownNCT05345873
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 300
Large-scale testing (Phase 3)Study completedNCT00814710
What this trial is testing

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age

Who this might be right for
Infections, StreptococcalStreptococcus Pneumoniae
GlaxoSmithKline 360
Testing effectiveness (Phase 2)Study completedNCT04368988
What this trial is testing

Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant

Who this might be right for
COVID-19
Novavax 1,419
Large-scale testing (Phase 3)Study completedNCT00346073
What this trial is testing

Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years

Who this might be right for
Acellular PertussisDiphtheriaTetanus
GlaxoSmithKline 2,337
Large-scale testing (Phase 3)UnknownNCT05616754
What this trial is testing

A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 400
Early research (Phase 1)Study completedNCT02231866
What this trial is testing

Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults

Who this might be right for
Healthy Adult Immune Responses to Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 143
Early research (Phase 1)Looking for participantsNCT07199270
What this trial is testing

Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2303 in Healthy Adult

Who this might be right for
Health Adult Subjects
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 64
Post-approval studies (Phase 4)Ended earlyNCT03591770
What this trial is testing

Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib

Who this might be right for
Inflammatory Bowel Diseases
Boston Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT04078022
What this trial is testing

Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine

Who this might be right for
Shigella
University of Maryland, Baltimore 58
Testing effectiveness (Phase 2)UnknownNCT06113731
What this trial is testing

A PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

Who this might be right for
SARS-CoV-2 Infection
CNBG-Virogin Biotech (Shanghai) Ltd. 980
Next Page